20/20 Biolabs, Inc.
Laboratory testing company · Rockville, Maryland, United States · Nasdaq: AIDX
20/20 Biolabs, Inc. is a laboratory testing company headquartered in Rockville, Maryland, United States. Its shares trade on Nasdaq under the ticker AIDX. It has received 17 US government small-business research awards (SBIR/STTR) from health agencies, $6.1 million in total, most recently in 2014. It has reported private securities offerings to the US SEC, most recently $70,000 sold in a notice filed in 2025.
20/20 Biolabs at a glance
What does 20/20 Biolabs do?
US government research funding
17 SBIR/STTR small-business research awards from US health agencies, $6.1 million in total (2003 to 2014).
Private fundraising reported to the SEC
5 Form D notices; the most recent reported $70,000 sold (2025).
Frequently asked questions about 20/20 Biolabs
Where is 20/20 Biolabs headquartered?
20/20 Biolabs, Inc. is headquartered in Rockville, Maryland, United States.
What does 20/20 Biolabs do?
20/20 Biolabs, Inc. is a laboratory testing company. Its SEC industry classification is Services-Testing Laboratories.
Is 20/20 Biolabs a public company?
Yes. 20/20 Biolabs, Inc. trades on Nasdaq under the ticker AIDX.
Similar companies
- Exact Sciences CorpMadison, Wisconsin, United States
- Guardant Health, Inc.Palo Alto, California, United States
- CareDx, Inc.Brisbane, California, United States
- Biodesix IncLouisville, Colorado, United States
- Dxterity Diagnostics IncCompton, California, United States
- Veracyte, Inc.South San Francisco, California, United States
- Aclarion, Inc.Broomfield, Colorado, United States
- Foundation Medicine, Inc.Cambridge, Massachusetts, United States
Work with CROs and CDMOs like 20/20 Biolabs
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences